Skip to main content
Top
Published in: Abdominal Radiology 12/2018

01-12-2018

Precision analysis of a quantitative CT liver surface nodularity score

Authors: Andrew Smith, Elliot Varney, Kevin Zand, Tara Lewis, Reza Sirous, James York, Edward Florez, Asser Abou Elkassem, Candace M. Howard-Claudio, Manohar Roda, Ellen Parker, Eduardo Scortegagna, David Joyner, David Sandlin, Ashley Newsome, Parker Brewster, Seth T. Lirette, Michael Griswold

Published in: Abdominal Radiology | Issue 12/2018

Login to get access

Abstract

Purpose

To evaluate precision of a software-based liver surface nodularity (LSN) score derived from CT images.

Methods

An anthropomorphic CT phantom was constructed with simulated liver containing smooth and nodular segments at the surface and simulated visceral and subcutaneous fat components. The phantom was scanned multiple times on a single CT scanner with adjustment of image acquisition and reconstruction parameters (N = 34) and on 22 different CT scanners from 4 manufacturers at 12 imaging centers. LSN scores were obtained using a software-based method. Repeatability and reproducibility were evaluated by intraclass correlation (ICC) and coefficient of variation. Using abdominal CT images from 68 patients with various stages of chronic liver disease, inter-observer agreement and test–retest repeatability among 12 readers assessing LSN by software- vs. visual-based scoring methods were evaluated by ICC.

Results

There was excellent repeatability of LSN scores (ICC:0.79-0.99) using the CT phantom and routine image acquisition and reconstruction parameters (kVp 100–140, mA 200–400, and auto-mA, section thickness 1.25–5.0 mm, field of view 35–50 cm, and smooth or standard kernels). There was excellent reproducibility (smooth ICC: 0.97; 95% CI 0.95, 0.99; CV: 7%; nodular ICC: 0.94; 95% CI 0.89, 0.97; CV: 8%) for LSN scores derived from CT images from 22 different scanners. Inter-observer agreement for the software-based LSN scoring method was excellent (ICC: 0.84; 95% CI 0.79, 0.88; CV: 28%) vs. good for the visual-based method (ICC: 0.61; 95% CI 0.51, 0.69; CV: 43%). Test–retest repeatability for the software-based LSN scoring method was excellent (ICC: 0.82; 95% CI 0.79, 0.84; CV: 12%).

Conclusion

The software-based LSN score is a quantitative CT imaging biomarker with excellent repeatability, reproducibility, inter-observer agreement, and test–retest repeatability.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tsochatzis E, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 383:1749–1761CrossRef Tsochatzis E, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 383:1749–1761CrossRef
2.
go back to reference Amico GD, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217–231CrossRef Amico GD, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217–231CrossRef
3.
4.
go back to reference Sangiovanni A, Prati GM, Fasani P, et al. (2006) The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 43:1303–1310CrossRef Sangiovanni A, Prati GM, Fasani P, et al. (2006) The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 43:1303–1310CrossRef
5.
go back to reference Ghany MG, Strader DB, Thoma DL, Seeff LB (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49:1335–1374CrossRef Ghany MG, Strader DB, Thoma DL, Seeff LB (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49:1335–1374CrossRef
6.
go back to reference Yee HS, Chang MF, Pocha C, et al. (2012) Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. Hepatology 107:669–689 Yee HS, Chang MF, Pocha C, et al. (2012) Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. Hepatology 107:669–689
7.
go back to reference George SL, Bacon BR, Brunt EM, et al. (2009) Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow up of 150 patients. Hepatology 49:729–738CrossRef George SL, Bacon BR, Brunt EM, et al. (2009) Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow up of 150 patients. Hepatology 49:729–738CrossRef
8.
go back to reference Poca M, Puente A, Graupera I, Villanueva C (2011) Prognostic markers in patients with cirrhosis and portal hypertension who have not bled. Dis Mark 31:147–154CrossRef Poca M, Puente A, Graupera I, Villanueva C (2011) Prognostic markers in patients with cirrhosis and portal hypertension who have not bled. Dis Mark 31:147–154CrossRef
9.
go back to reference D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217–231CrossRef D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217–231CrossRef
10.
go back to reference Kudo M, Zheng RQ, Kim SR, et al. (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. Intervirology 51:17–26CrossRef Kudo M, Zheng RQ, Kim SR, et al. (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. Intervirology 51:17–26CrossRef
11.
go back to reference Saygili OB, Tarhan NC, Yildirim T, et al. (2005) Value of computed tomography and magnetic resonance imaging for assessing severity of liver cirrhosis secondary to viral hepatitis. Eur J Radiol 54:400–407CrossRef Saygili OB, Tarhan NC, Yildirim T, et al. (2005) Value of computed tomography and magnetic resonance imaging for assessing severity of liver cirrhosis secondary to viral hepatitis. Eur J Radiol 54:400–407CrossRef
12.
go back to reference Smith AD, Brach CR, Subramony C, et al. (2016) Liver surface nodularity quantification from routine CT images as a biomarker for detection and evaluation of cirrhosis. Radiology 280:771–781CrossRef Smith AD, Brach CR, Subramony C, et al. (2016) Liver surface nodularity quantification from routine CT images as a biomarker for detection and evaluation of cirrhosis. Radiology 280:771–781CrossRef
13.
go back to reference Pickhardt PJ, Malecki K, Kloke J, Lubner MG (2016) Accuracy of liver surface nodularity quantification on MDCT as a noninvasive biomarker for staging hepatic fibrosis. Am J Roentgenol 207:1194–1199CrossRef Pickhardt PJ, Malecki K, Kloke J, Lubner MG (2016) Accuracy of liver surface nodularity quantification on MDCT as a noninvasive biomarker for staging hepatic fibrosis. Am J Roentgenol 207:1194–1199CrossRef
14.
go back to reference Smith AD, Shlapak D, Zand K, et al. (2017) Liver surface nodularity score allows prediction of cirrhosis decompensation and death. Radiology 283(3):711–722CrossRef Smith AD, Shlapak D, Zand K, et al. (2017) Liver surface nodularity score allows prediction of cirrhosis decompensation and death. Radiology 283(3):711–722CrossRef
15.
go back to reference Castera L (2012) Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterol 142:1293–1302CrossRef Castera L (2012) Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterol 142:1293–1302CrossRef
16.
go back to reference Rockey D, Bissell DM (2006) Noninvasive measures of liver fibrosis. Hepatology 43:S113–S120CrossRef Rockey D, Bissell DM (2006) Noninvasive measures of liver fibrosis. Hepatology 43:S113–S120CrossRef
17.
go back to reference Nguyen D, Talwalkar JA (2011) Noninvasive assessment of liver fibrosis. Hepatology 53:2107–2110CrossRef Nguyen D, Talwalkar JA (2011) Noninvasive assessment of liver fibrosis. Hepatology 53:2107–2110CrossRef
18.
go back to reference Holmberg SD, Lu M, Rupp LB, et al. (2013) Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis 57:240–246CrossRef Holmberg SD, Lu M, Rupp LB, et al. (2013) Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis 57:240–246CrossRef
19.
go back to reference Singh S, Venkatesh SK, Wang Z, et al. (2015) Diagnostics performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 13:440–451CrossRef Singh S, Venkatesh SK, Wang Z, et al. (2015) Diagnostics performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 13:440–451CrossRef
20.
go back to reference Tsochatzis EA, Gurusamy KS, Ntaoula S, et al. (2011) Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 54:650–659CrossRef Tsochatzis EA, Gurusamy KS, Ntaoula S, et al. (2011) Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 54:650–659CrossRef
21.
go back to reference Stebbing J, Farouk L, Panos G, et al. (2010) A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 44:214–219CrossRef Stebbing J, Farouk L, Panos G, et al. (2010) A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 44:214–219CrossRef
22.
go back to reference Venkatesh SK, Yin M, Ehman R (2013) Magnetic resonance elastography of the liver: technique, analysis, and clinical applications. J Magn Reson Imaging 37:544–555CrossRef Venkatesh SK, Yin M, Ehman R (2013) Magnetic resonance elastography of the liver: technique, analysis, and clinical applications. J Magn Reson Imaging 37:544–555CrossRef
23.
go back to reference Rustogi R, Horowitz J, Harmath C, et al. (2012) Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 35:1356–1364CrossRef Rustogi R, Horowitz J, Harmath C, et al. (2012) Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 35:1356–1364CrossRef
24.
go back to reference Moon KM, Baik SK, Choi E, et al. (2013) Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis. Clin Mol Hepatol 19:389–398CrossRef Moon KM, Baik SK, Choi E, et al. (2013) Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis. Clin Mol Hepatol 19:389–398CrossRef
25.
go back to reference Zheng J, Guo H, Zeng J, et al. (2015) Two-dimensional shear-wave elastography and conventional US: the optimal evaluation of liver fibrosis and cirrhosis. Radiology 275:290–300CrossRef Zheng J, Guo H, Zeng J, et al. (2015) Two-dimensional shear-wave elastography and conventional US: the optimal evaluation of liver fibrosis and cirrhosis. Radiology 275:290–300CrossRef
26.
go back to reference Raunig D, McShane L, Pennello G, et al. (2015) Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. J Stat Methods Med Res 24:27–67CrossRef Raunig D, McShane L, Pennello G, et al. (2015) Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. J Stat Methods Med Res 24:27–67CrossRef
27.
go back to reference Sullivan D, Obuchowski N, Kessler L, et al. (2015) Metrology standards for quantitative imaging biomarkers. Radiology 277:813–825CrossRef Sullivan D, Obuchowski N, Kessler L, et al. (2015) Metrology standards for quantitative imaging biomarkers. Radiology 277:813–825CrossRef
28.
go back to reference Ferral H, Male R, Cardiel M, Munoz L (1992) Quiroz y Ferrari F. Cirrhosis: diagnosis by liver surface analysis with high-frequency ultrasound. Gastrointest Radiol 17:74–78CrossRef Ferral H, Male R, Cardiel M, Munoz L (1992) Quiroz y Ferrari F. Cirrhosis: diagnosis by liver surface analysis with high-frequency ultrasound. Gastrointest Radiol 17:74–78CrossRef
29.
go back to reference Kudo M, Zheng RQ, Kim SR, et al. (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology 51:17–26PubMed Kudo M, Zheng RQ, Kim SR, et al. (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology 51:17–26PubMed
30.
go back to reference Trout AT, Serai S, Mahley AD, et al. (2016) Liver stiffness measurements with MR elastography: agreement and repeatability across imaging systems, field strengths, and pulse sequences. Radiology 281:793–804CrossRef Trout AT, Serai S, Mahley AD, et al. (2016) Liver stiffness measurements with MR elastography: agreement and repeatability across imaging systems, field strengths, and pulse sequences. Radiology 281:793–804CrossRef
Metadata
Title
Precision analysis of a quantitative CT liver surface nodularity score
Authors
Andrew Smith
Elliot Varney
Kevin Zand
Tara Lewis
Reza Sirous
James York
Edward Florez
Asser Abou Elkassem
Candace M. Howard-Claudio
Manohar Roda
Ellen Parker
Eduardo Scortegagna
David Joyner
David Sandlin
Ashley Newsome
Parker Brewster
Seth T. Lirette
Michael Griswold
Publication date
01-12-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 12/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1617-x

Other articles of this Issue 12/2018

Abdominal Radiology 12/2018 Go to the issue

Classics in Abdominal Radiology

The “Christmas tree” bladder

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.